Clinical Efficacy of Therapeutic Drug Monitoring in Patients Receiving Vancomycin
- 1 January 2003
- journal article
- Published by Pharmaceutical Society of Japan in Biological & Pharmaceutical Bulletin
- Vol. 26 (6) , 876-879
- https://doi.org/10.1248/bpb.26.876
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 21 references indexed in Scilit:
- The therapeutic monitoring of antimicrobial agentsBritish Journal of Clinical Pharmacology, 1999
- Penetration of vancomycin into human lung tissueJournal of Antimicrobial Chemotherapy, 1996
- Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic responseAntimicrobial Agents and Chemotherapy, 1992
- Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus EndocarditisAnnals of Internal Medicine, 1991
- Nephrotoxicity of vancomycin, alone and with an aminoglycosideJournal of Antimicrobial Chemotherapy, 1990
- Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infantsEuropean Journal of Clinical Pharmacology, 1988
- Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapyThe American Journal of Medicine, 1987
- Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981Antimicrobial Agents and Chemotherapy, 1983
- The Antibacterial Action of VancomycinClinical Infectious Diseases, 1981
- Clinical pharmacology and efficacy of vancomycin in pediatric patientsThe Journal of Pediatrics, 1980